|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Evaluation and optimization of different cationic liposome formulations for in vivo gene transfer显示文摘 | Egilmez NK Lwanuma Y Bankert RB | 1996 | Biochem Biophys Res Commun1996，221，1： | 1 |
| 2 | Membrane-associated TGF-betal inhibits human memory T cell signaling in malignant and nonmalignant inflammatory microenvironments显示文摘 | Broderick L Bankert RB | | 0，，05： | 1 |
| 3 | Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends Immunol2001，22，7： | 1 |
| 4 | The next generation of li- posome delivery systems :recent experience with tumor-targe-ted, sterically-stabilized immunoliposomes and active-loading gradients显示文摘 | Abra RM Bankert RB Chen F etal | 2002 | J Liposome Res2002，12，： | 1 |
| 5 | SCID mouse models to study human cancer pathogenesis and approaches to therapy: potential, limitations, and future directions 显示文摘 | Bankert RB Hess SD Egilmez NK | 2002 | Front Biosci2002，7，： | 1 |
| 6 | The next generation of lipo- some delivery systems: recent experience with tumor-targeted, steri- cally-stabilized immunoliposomes and active-loading gradients 显示文摘 | Abra RM Bankert RB Chen F | 2002 | J Liposome Res2002，12，12： | 1 |
| 7 | Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends Immunol2001，22，7： | 1 |
| 8 | Human- SCID mouse chimeric models for the evaluation of anti- cancer therapies显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends Immunol2001，22，： | 1 |
| 9 | SCID mouse models to study human cancer pathogenesis and approahes to therapy: potential,limitations,and future directions显示文摘 | Bankert RB Hess SD Egilmez NK | 2002 | Front Biosci2002，7，： | 1 |
| 10 | The next generation of liposome deliv -ery systems: recent experience with tumor - targeted, sterically - stabilized immunoliposomes and active - loading gradients 显示文摘 | Abra RM Bankert RB Chen F | 2002 | J Liposome Res2002，12，12： | 1 |
| 11 | Human-SCID mouse chimeric models for the evaluation of anti cancer therapies 显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends Immunol2001，22，7： | 1 |
| 12 | Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies 显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends Im- munol2001，22，7： | 1 |
| 13 | Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies 显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends Immunol2001，22，： | 1 |
| 14 | Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends Immunol2001，22，7： | 1 |
| 15 | Human-SCID mouse chimeric models for the evaluation of anti-cancer therapies显示文摘 | Bankert RB Egilmez NK Hess SD | 2001 | Trends in Immunology2001，22，7： | 1 |
| 16 | SCID mouse models to study human cancer pathogenesis and approaches to therapy:potential,limitations,and future directions显示文摘 | Bankert RB Hess SD Egilmez NK | 2002 | Front Biosci2002，7，： | 1 |
| 17 | The next generation of liposome delivery systems: recent experience with tumor-targeted, steritally-stabilized immunoliposomes and active-loading gradients显示文摘 | Abra RM Bankert RB Chen F | 2002 | J Liposome Res2002，12，： | 1 |
| 18 | SCID mouse models to study hu- man cancer pathogenesis and approaches to therapy: potential, limitations, and future directions显示文摘 | Bankert RB Hess SD Egilmez NK | 2002 | Front Biosci2002，7，： | 1 |
| 19 | The next generation of liposome delivery systems: recent experience with tumor-targeted, sterically-stabilized immunnliposomes and activeloading gradients显示文摘 | ABRA RM BANKERT RB CHEN F | 2002 | J Liposome Res2002，12，12： | 1 |
| 20 | Humanized mouse model of ovarian cancer recapitulates patient solid tumor progression, ascites formation, and metastasis显示文摘 | Bankert RB Balu-Iyer SV Odunsi K | 2011 | PLoS One2011，6，24： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员